Literature DB >> 8289289

Structure of human factor D. A complement system protein at 2.0 A resolution.

S V Narayana1, M Carson, O el-Kabbani, J M Kilpatrick, D Moore, X Chen, C E Bugg, J E Volanakis, L J DeLucas.   

Abstract

Factor D, an essential enzyme for the activation of the alternative pathway of the complement system, belongs to the serine protease superfamily. The crystal structure of the enzyme was solved by a combination of multiple isomorphous replacement and molecular replacement methods. The present model was refined to an R-factor of 18.8% using 23,681 observed reflections between 7.5 and 2.0 A resolution, with a root-mean-square deviation from standard bond lengths of 0.016 A. The two non-crystallographically related molecules in the triclinic unit cell have distinctive active site conformations. The protein has the general structural fold of a serine protease, but there are several unique amino acid substitutions resulting in significant alterations in the critical loops responsible for catalysis and substrate specificity in serine proteases. Factor D is the first complement serine protease whose three-dimensional structure has been determined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289289     DOI: 10.1006/jmbi.1994.1021

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  32 in total

Review 1.  Conformational selection in trypsin-like proteases.

Authors:  Nicola Pozzi; Austin D Vogt; David W Gohara; Enrico Di Cera
Journal:  Curr Opin Struct Biol       Date:  2012-06-03       Impact factor: 6.809

2.  Exposure of R169 controls protein C activation and autoactivation.

Authors:  Nicola Pozzi; Sergio Barranco-Medina; Zhiwei Chen; Enrico Di Cera
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

3.  Inhibiting alternative pathway complement activation by targeting the factor D exosite.

Authors:  Kenneth J Katschke; Ping Wu; Rajkumar Ganesan; Robert F Kelley; Mary A Mathieu; Philip E Hass; Jeremy Murray; Daniel Kirchhofer; Christian Wiesmann; Menno van Lookeren Campagne
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

4.  Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.

Authors:  Davide Serruto; Rino Rappuoli; Maria Scarselli; Piet Gros; Jos A G van Strijp
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

Review 5.  Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.

Authors:  S R Barnum
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

6.  MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes.

Authors:  Asli Sirmaci; Tom Walsh; Hatice Akay; Michail Spiliopoulos; Yıldırım Bayezit Sakalar; Aylin Hasanefendioğlu-Bayrak; Duygu Duman; Amjad Farooq; Mary-Claire King; Mustafa Tekin
Journal:  Am J Hum Genet       Date:  2010-10-28       Impact factor: 11.025

Review 7.  Complement-targeted therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Nat Biotechnol       Date:  2007-11       Impact factor: 54.908

8.  Effect of zymogen domains and active site occupation on activation of prothrombin by von Willebrand factor-binding protein.

Authors:  Heather K Kroh; Paul E Bock
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

9.  Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D.

Authors:  Anna Vulpetti; Nils Ostermann; Stefan Randl; Taeyoung Yoon; Aengus Mac Sweeney; Frederic Cumin; Edwige Lorthiois; Simon Rüdisser; Paul Erbel; Jürgen Maibaum
Journal:  ACS Med Chem Lett       Date:  2018-04-24       Impact factor: 4.345

Review 10.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.